Table of Content

1 Antiretroviral Therapy Market Overview
1.1 Antiretroviral Therapy Product Scope
1.2 Antiretroviral Therapy Segment by Type
1.2.1 Global Antiretroviral Therapy Sales by Type (2016 & 2021 & 2027)
1.2.2 NNRTIs
1.2.3 NRTI
1.2.4 Multiclass Combination Products
1.2.5 Integrase Inhibitors
1.3 Antiretroviral Therapy Segment by Application
1.3.1 Global Antiretroviral Therapy Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Antiretroviral Therapy Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antiretroviral Therapy Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antiretroviral Therapy Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antiretroviral Therapy Price Trends (2016-2027)

2 Antiretroviral Therapy Estimates and Forecasts by Region
2.1 Global Antiretroviral Therapy Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antiretroviral Therapy Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antiretroviral Therapy Sales Market Share by Region (2016-2021)
2.2.2 Global Antiretroviral Therapy Revenue Market Share by Region (2016-2021)
2.3 Global Antiretroviral Therapy Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antiretroviral Therapy Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antiretroviral Therapy Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antiretroviral Therapy Estimates and Projections (2016-2027)
2.4.2 Europe Antiretroviral Therapy Estimates and Projections (2016-2027)
2.4.3 China Antiretroviral Therapy Estimates and Projections (2016-2027)
2.4.4 Japan Antiretroviral Therapy Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antiretroviral Therapy Estimates and Projections (2016-2027)
2.4.6 India Antiretroviral Therapy Estimates and Projections (2016-2027)

3 Global Antiretroviral Therapy Competition Landscape by Players
3.1 Global Top Antiretroviral Therapy Players by Sales (2016-2021)
3.2 Global Top Antiretroviral Therapy Players by Revenue (2016-2021)
3.3 Global Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2020)
3.4 Global Antiretroviral Therapy Average Price by Company (2016-2021)
3.5 Manufacturers Antiretroviral Therapy Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Antiretroviral Therapy Market Size by Type
4.1 Global Antiretroviral Therapy Historic Market Review by Type (2016-2021)
4.1.1 Global Antiretroviral Therapy Sales Market Share by Type (2016-2021)
4.1.2 Global Antiretroviral Therapy Revenue Market Share by Type (2016-2021)
4.1.3 Global Antiretroviral Therapy Price by Type (2016-2021)
4.2 Global Antiretroviral Therapy Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antiretroviral Therapy Sales Forecast by Type (2022-2027)
4.2.2 Global Antiretroviral Therapy Revenue Forecast by Type (2022-2027)
4.2.3 Global Antiretroviral Therapy Price Forecast by Type (2022-2027)

5 Global Antiretroviral Therapy Market Size by Application
5.1 Global Antiretroviral Therapy Historic Market Review by Application (2016-2021)
5.1.1 Global Antiretroviral Therapy Sales Market Share by Application (2016-2021)
5.1.2 Global Antiretroviral Therapy Revenue Market Share by Application (2016-2021)
5.1.3 Global Antiretroviral Therapy Price by Application (2016-2021)
5.2 Global Antiretroviral Therapy Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antiretroviral Therapy Sales Forecast by Application (2022-2027)
5.2.2 Global Antiretroviral Therapy Revenue Forecast by Application (2022-2027)
5.2.3 Global Antiretroviral Therapy Price Forecast by Application (2022-2027)

6 North America Antiretroviral Therapy Market Facts & Figures
6.1 North America Antiretroviral Therapy Sales by Company
6.1.1 North America Antiretroviral Therapy Sales by Company (2016-2021)
6.1.2 North America Antiretroviral Therapy Revenue by Company (2016-2021)
6.2 North America Antiretroviral Therapy Sales Breakdown by Type
6.2.1 North America Antiretroviral Therapy Sales Breakdown by Type (2016-2021)
6.2.2 North America Antiretroviral Therapy Sales Breakdown by Type (2022-2027)
6.3 North America Antiretroviral Therapy Sales Breakdown by Application
6.3.1 North America Antiretroviral Therapy Sales Breakdown by Application (2016-2021)
6.3.2 North America Antiretroviral Therapy Sales Breakdown by Application (2022-2027)

7 Europe Antiretroviral Therapy Market Facts & Figures
7.1 Europe Antiretroviral Therapy Sales by Company
7.1.1 Europe Antiretroviral Therapy Sales by Company (2016-2021)
7.1.2 Europe Antiretroviral Therapy Revenue by Company (2016-2021)
7.2 Europe Antiretroviral Therapy Sales Breakdown by Type
7.2.1 Europe Antiretroviral Therapy Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antiretroviral Therapy Sales Breakdown by Type (2022-2027)
7.3 Europe Antiretroviral Therapy Sales Breakdown by Application
7.3.1 Europe 123 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 123 Sales Breakdown by Application (2022-2027)

8 China Antiretroviral Therapy Market Facts & Figures
8.1 China Antiretroviral Therapy Sales by Company
8.1.1 China Antiretroviral Therapy Sales by Company (2016-2021)
8.1.2 China Antiretroviral Therapy Revenue by Company (2016-2021)
8.2 China Antiretroviral Therapy Sales Breakdown by Type
8.2.1 China Antiretroviral Therapy Sales Breakdown by Type (2016-2021)
8.2.2 China Antiretroviral Therapy Sales Breakdown by Type (2022-2027)
8.3 China Antiretroviral Therapy Sales Breakdown by Application
8.3.1 China 146 Sales Breakdown by Application (2016-2021)
8.3.2 China 146 Sales Breakdown by Application (2022-2027)

9 Japan Antiretroviral Therapy Market Facts & Figures
9.1 Japan Antiretroviral Therapy Sales by Company
9.1.1 Japan Antiretroviral Therapy Sales by Company (2016-2021)
9.1.2 Japan Antiretroviral Therapy Revenue by Company (2016-2021)
9.2 Japan Antiretroviral Therapy Sales Breakdown by Type
9.2.1 Japan Antiretroviral Therapy Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antiretroviral Therapy Sales Breakdown by Type (2022-2027)
9.3 Japan Antiretroviral Therapy Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Antiretroviral Therapy Market Facts & Figures
10.1 Southeast Asia Antiretroviral Therapy Sales by Company
10.1.1 Southeast Asia Antiretroviral Therapy Sales by Company (2016-2021)
10.1.2 Southeast Asia Antiretroviral Therapy Revenue by Company (2016-2021)
10.2 Southeast Asia Antiretroviral Therapy Sales Breakdown by Type
10.2.1 Southeast Asia Antiretroviral Therapy Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antiretroviral Therapy Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antiretroviral Therapy Sales Breakdown by Application
10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)

11 India Antiretroviral Therapy Market Facts & Figures
11.1 India Antiretroviral Therapy Sales by Company
11.1.1 India Antiretroviral Therapy Sales by Company (2016-2021)
11.1.2 India Antiretroviral Therapy Revenue by Company (2016-2021)
11.2 India Antiretroviral Therapy Sales Breakdown by Type
11.2.1 India Antiretroviral Therapy Sales Breakdown by Type (2016-2021)
11.2.2 India Antiretroviral Therapy Sales Breakdown by Type (2022-2027)
11.3 India Antiretroviral Therapy Sales Breakdown by Application
11.3.1 India Antiretroviral Therapy Sales Breakdown by Application (2016-2021)
11.3.2 India Antiretroviral Therapy Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Antiretroviral Therapy Business
12.1 Gilead
12.1.1 Gilead Corporation Information
12.1.2 Gilead Business Overview
12.1.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Antiretroviral Therapy Products Offered
12.1.5 Gilead Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Corporation Information
12.2.2 F. Hoffmann-La Roche Business Overview
12.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Products Offered
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 ViiV Healthcare
12.3.1 ViiV Healthcare Corporation Information
12.3.2 ViiV Healthcare Business Overview
12.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.3.4 ViiV Healthcare Antiretroviral Therapy Products Offered
12.3.5 ViiV Healthcare Recent Development
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Corporation Information
12.4.2 Boehringer Ingelheim Business Overview
12.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Boehringer Ingelheim Antiretroviral Therapy Products Offered
12.4.5 Boehringer Ingelheim Recent Development
12.5 Janssen Pharmaceuticals
12.5.1 Janssen Pharmaceuticals Corporation Information
12.5.2 Janssen Pharmaceuticals Business Overview
12.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Products Offered
12.5.5 Janssen Pharmaceuticals Recent Development
12.6 Mylan
12.6.1 Mylan Corporation Information
12.6.2 Mylan Business Overview
12.6.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Mylan Antiretroviral Therapy Products Offered
12.6.5 Mylan Recent Development
12.7 Abbvie
12.7.1 Abbvie Corporation Information
12.7.2 Abbvie Business Overview
12.7.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abbvie Antiretroviral Therapy Products Offered
12.7.5 Abbvie Recent Development
12.8 Bionor Pharma
12.8.1 Bionor Pharma Corporation Information
12.8.2 Bionor Pharma Business Overview
12.8.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bionor Pharma Antiretroviral Therapy Products Offered
12.8.5 Bionor Pharma Recent Development
12.9 Vertex Pharmaceuticals
12.9.1 Vertex Pharmaceuticals Corporation Information
12.9.2 Vertex Pharmaceuticals Business Overview
12.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Products Offered
12.9.5 Vertex Pharmaceuticals Recent Development

13 Antiretroviral Therapy Manufacturing Cost Analysis
13.1 Antiretroviral Therapy Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antiretroviral Therapy
13.4 Antiretroviral Therapy Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antiretroviral Therapy Distributors List
14.3 Antiretroviral Therapy Customers

15 Market Dynamics
15.1 Antiretroviral Therapy Market Trends
15.2 Antiretroviral Therapy Drivers
15.3 Antiretroviral Therapy Market Challenges
15.4 Antiretroviral Therapy Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antiretroviral Therapy Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Antiretroviral Therapy Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Antiretroviral Therapy Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Antiretroviral Therapy Sales (KG) by Region (2016-2021)
Table 5. Global Antiretroviral Therapy Sales Market Share by Region (2016-2021)
Table 6. Global Antiretroviral Therapy Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Antiretroviral Therapy Revenue Share by Region (2016-2021)
Table 8. Global Antiretroviral Therapy Sales (KG) Forecast by Region (2022-2027)
Table 9. Global Antiretroviral Therapy Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Antiretroviral Therapy Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Antiretroviral Therapy Revenue Share Forecast by Region (2022-2027)
Table 12. Global Antiretroviral Therapy Sales (KG) of Key Companies (2016-2021)
Table 13. Global Antiretroviral Therapy Sales Share by Company (2016-2021)
Table 14. Global Antiretroviral Therapy Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Antiretroviral Therapy Revenue Share by Company (2016-2021)
Table 16. Global Antiretroviral Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Therapy as of 2020)
Table 17. Global Antiretroviral Therapy Average Price (USD/KG) of Key Company (2016-2021)
Table 18. Manufacturers Antiretroviral Therapy Manufacturing Sites and Area Served
Table 19. Manufacturers Antiretroviral Therapy Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Antiretroviral Therapy Sales (KG) by Type (2016-2021)
Table 22. Global Antiretroviral Therapy Sales Share by Type (2016-2021)
Table 23. Global Antiretroviral Therapy Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Antiretroviral Therapy Price (USD/KG) by Type (2016-2021)
Table 25. Global Antiretroviral Therapy Sales Share by Type (2022-2027)
Table 26. Global Antiretroviral Therapy Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Antiretroviral Therapy Revenue Share by Type (2022-2027)
Table 28. Global Antiretroviral Therapy Price (USD/KG) by Type (2022-2027)
Table 29. Global Antiretroviral Therapy Sales (KG) by Application (2016-2021)
Table 30. Global Antiretroviral Therapy Sales Share by Application (2016-2021)
Table 31. Global Antiretroviral Therapy Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Antiretroviral Therapy Price (USD/KG) by Application (2016-2021)
Table 33. Global Antiretroviral Therapy Sales (KG) by Application (2022-2027)
Table 34. Global Antiretroviral Therapy Sales Share by Application (2022-2027)
Table 35. Global Antiretroviral Therapy Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Antiretroviral Therapy Revenue Share by Application (2022-2027)
Table 37. Global Antiretroviral Therapy Price (USD/KG) by Application (2022-2027)
Table 38. North America Antiretroviral Therapy Sales (KG) by Company (2016-2021)
Table 39. North America Antiretroviral Therapy Sales Market Share by Company (2016-2021)
Table 40. North America Antiretroviral Therapy Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Antiretroviral Therapy Revenue Market Share by Company (2016-2021)
Table 42. North America Antiretroviral Therapy Sales by Type (2016-2021) & (KG)
Table 43. North America Antiretroviral Therapy Sales Market Share by Type (2016-2021)
Table 44. North America Antiretroviral Therapy Sales by Type (2022-2027) & (KG)
Table 45. North America Antiretroviral Therapy Sales Market Share by Type (2022-2027)
Table 46. North America Antiretroviral Therapy Sales by Application (2016-2021) & (KG)
Table 47. North America Antiretroviral Therapy Sales Market Share by Application (2016-2021)
Table 48. North America Antiretroviral Therapy Sales by Application (2022-2027) & (KG)
Table 49. North America Antiretroviral Therapy Sales Market Share by Application (2022-2027)
Table 50. Europe Antiretroviral Therapy Sales (KG) by Company (2016-2021)
Table 51. Europe Antiretroviral Therapy Sales Market Share by Company (2016-2021)
Table 52. Europe Antiretroviral Therapy Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Antiretroviral Therapy Revenue Market Share by Company (2016-2021)
Table 54. Europe Antiretroviral Therapy Sales by Type (2016-2021) & (KG)
Table 55. Europe Antiretroviral Therapy Sales Market Share by Type (2016-2021)
Table 56. Europe Antiretroviral Therapy Sales by Type (2022-2027) & (KG)
Table 57. Europe Antiretroviral Therapy Sales Market Share by Type (2022-2027)
Table 58. Europe Antiretroviral Therapy Sales by Application (2016-2021) & (KG)
Table 59. Europe Antiretroviral Therapy Sales Market Share by Application (2016-2021)
Table 60. Europe Antiretroviral Therapy Sales by Application (2022-2027) & (KG)
Table 61. Europe Antiretroviral Therapy Sales Market Share by Application (2022-2027)
Table 62. China Antiretroviral Therapy Sales (KG) by Company (2016-2021)
Table 63. China Antiretroviral Therapy Sales Market Share by Company (2016-2021)
Table 64. China Antiretroviral Therapy Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Antiretroviral Therapy Revenue Market Share by Company (2016-2021)
Table 66. China Antiretroviral Therapy Sales by Type (2016-2021) & (KG)
Table 67. China Antiretroviral Therapy Sales Market Share by Type (2016-2021)
Table 68. China Antiretroviral Therapy Sales by Type (2022-2027) & (KG)
Table 69. China Antiretroviral Therapy Sales Market Share by Type (2022-2027)
Table 70. China Antiretroviral Therapy Sales by Application (2016-2021) & (KG)
Table 71. China Antiretroviral Therapy Sales Market Share by Application (2016-2021)
Table 72. China Antiretroviral Therapy Sales by Application (2022-2027) & (KG)
Table 73. China Antiretroviral Therapy Sales Market Share by Application (2022-2027)
Table 74. Japan Antiretroviral Therapy Sales (KG) by Company (2016-2021)
Table 75. Japan Antiretroviral Therapy Sales Market Share by Company (2016-2021)
Table 76. Japan Antiretroviral Therapy Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Antiretroviral Therapy Revenue Market Share by Company (2016-2021)
Table 78. Japan Antiretroviral Therapy Sales by Type (2016-2021) & (KG)
Table 79. Japan Antiretroviral Therapy Sales Market Share by Type (2016-2021)
Table 80. Japan Antiretroviral Therapy Sales by Type (2022-2027) & (KG)
Table 81. Japan Antiretroviral Therapy Sales Market Share by Type (2022-2027)
Table 82. Japan Antiretroviral Therapy Sales by Application (2016-2021) & (KG)
Table 83. Japan Antiretroviral Therapy Sales Market Share by Application (2016-2021)
Table 84. Japan Antiretroviral Therapy Sales by Application (2022-2027) & (KG)
Table 85. Japan Antiretroviral Therapy Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Antiretroviral Therapy Sales (KG) by Company (2016-2021)
Table 87. Southeast Asia Antiretroviral Therapy Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Antiretroviral Therapy Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Antiretroviral Therapy Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Antiretroviral Therapy Sales by Type (2016-2021) & (KG)
Table 91. Southeast Asia Antiretroviral Therapy Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Antiretroviral Therapy Sales by Type (2022-2027) & (KG)
Table 93. Southeast Asia Antiretroviral Therapy Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Antiretroviral Therapy Sales by Application (2016-2021) & (KG)
Table 95. Southeast Asia Antiretroviral Therapy Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Antiretroviral Therapy Sales by Application (2022-2027) & (KG)
Table 97. Southeast Asia Antiretroviral Therapy Sales Market Share by Application (2022-2027)
Table 98. India Antiretroviral Therapy Sales (KG) by Company (2016-2021)
Table 99. India Antiretroviral Therapy Sales Market Share by Company (2016-2021)
Table 100. India Antiretroviral Therapy Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Antiretroviral Therapy Revenue Market Share by Company (2016-2021)
Table 102. India Antiretroviral Therapy Sales by Type (2016-2021) & (KG)
Table 103. India Antiretroviral Therapy Sales Market Share by Type (2016-2021)
Table 104. India Antiretroviral Therapy Sales by Type (2022-2027) & (KG)
Table 105. India Antiretroviral Therapy Sales Market Share by Type (2022-2027)
Table 106. India Antiretroviral Therapy Sales by Application (2016-2021) & (KG)
Table 107. India Antiretroviral Therapy Sales Market Share by Application (2016-2021)
Table 108. India Antiretroviral Therapy Sales by Application (2022-2027) & (KG)
Table 109. India Antiretroviral Therapy Sales Market Share by Application (2022-2027)
Table 110. Gilead Corporation Information
Table 111. Gilead Description and Business Overview
Table 112. Gilead Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 113. Gilead Antiretroviral Therapy Product
Table 114. Gilead Recent Development
Table 115. F. Hoffmann-La Roche Corporation Information
Table 116. F. Hoffmann-La Roche Description and Business Overview
Table 117. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 118. F. Hoffmann-La Roche Antiretroviral Therapy Product
Table 119. F. Hoffmann-La Roche Recent Development
Table 120. ViiV Healthcare Corporation Information
Table 121. ViiV Healthcare Description and Business Overview
Table 122. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 123. ViiV Healthcare Antiretroviral Therapy Product
Table 124. ViiV Healthcare Recent Development
Table 125. Boehringer Ingelheim Corporation Information
Table 126. Boehringer Ingelheim Description and Business Overview
Table 127. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 128. Boehringer Ingelheim Antiretroviral Therapy Product
Table 129. Boehringer Ingelheim Recent Development
Table 130. Janssen Pharmaceuticals Corporation Information
Table 131. Janssen Pharmaceuticals Description and Business Overview
Table 132. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 133. Janssen Pharmaceuticals Antiretroviral Therapy Product
Table 134. Janssen Pharmaceuticals Recent Development
Table 135. Mylan Corporation Information
Table 136. Mylan Description and Business Overview
Table 137. Mylan Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 138. Mylan Antiretroviral Therapy Product
Table 139. Mylan Recent Development
Table 140. Abbvie Corporation Information
Table 141. Abbvie Description and Business Overview
Table 142. Abbvie Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 143. Abbvie Antiretroviral Therapy Product
Table 144. Abbvie Recent Development
Table 145. Bionor Pharma Corporation Information
Table 146. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 147. Bionor Pharma Description and Business Overview
Table 148. Bionor Pharma Antiretroviral Therapy Product
Table 149. Bionor Pharma Recent Development
Table 150. Vertex Pharmaceuticals Corporation Information
Table 151. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 152. Vertex Pharmaceuticals Description and Business Overview
Table 153. Vertex Pharmaceuticals Antiretroviral Therapy Product
Table 154. Vertex Pharmaceuticals Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Antiretroviral Therapy Distributors List
Table 158. Antiretroviral Therapy Customers List
Table 159. Antiretroviral Therapy Market Trends
Table 160. Antiretroviral Therapy Market Drivers
Table 161. Antiretroviral Therapy Market Challenges
Table 162. Antiretroviral Therapy Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 2. Global Antiretroviral Therapy Sales Market Share by Type in 2021 & 2027
Figure 3. NNRTIs Product Picture
Figure 4. NRTI Product Picture
Figure 5. Multiclass Combination Products Product Picture
Figure 6. Integrase Inhibitors Product Picture
Figure 7. Global Antiretroviral Therapy Sales Market Share by Application in 2021 & 2027
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global Antiretroviral Therapy Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Antiretroviral Therapy Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Antiretroviral Therapy Sales (KG) Growth Rate (2016-2027)
Figure 14. Global Antiretroviral Therapy Price Trends Growth Rate (2016-2027) (USD/KG)
Figure 15. Global Antiretroviral Therapy Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Antiretroviral Therapy Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Antiretroviral Therapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Antiretroviral Therapy Sales (KG) Growth Rate (2016-2027)
Figure 19. Europe Antiretroviral Therapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Antiretroviral Therapy Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Antiretroviral Therapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Antiretroviral Therapy Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Antiretroviral Therapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Antiretroviral Therapy Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Antiretroviral Therapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Antiretroviral Therapy Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Antiretroviral Therapy Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Antiretroviral Therapy Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Antiretroviral Therapy Players Market Share by Revenue in Antiretroviral Therapy: 2016 & 2020
Figure 30. Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Antiretroviral Therapy Revenue Share by Type (2016-2021)
Figure 32. Global Antiretroviral Therapy Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Antiretroviral Therapy Revenue Share by Application (2016-2021)
Figure 34. Global Antiretroviral Therapy Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Antiretroviral Therapy Sales Market Share by Type in 2020
Figure 36. North America Antiretroviral Therapy Sales Market Share by Application in 2020
Figure 37. Europe Antiretroviral Therapy Sales Market Share by Type in 2020
Figure 38. Europe Antiretroviral Therapy Sales Market Share by Application in 2020
Figure 39. China Antiretroviral Therapy Sales Market Share by Type in 2020
Figure 40. China Antiretroviral Therapy Sales Market Share by Application in 2020
Figure 41. Japan Antiretroviral Therapy Sales Market Share by Type in 2020
Figure 42. Japan Antiretroviral Therapy Sales Market Share by Application in 2020
Figure 43. Southeast Asia Antiretroviral Therapy Sales Market Share by Type in 2020
Figure 44. Southeast Asia Antiretroviral Therapy Sales Market Share by Application in 2020
Figure 45. India Antiretroviral Therapy Sales Market Share by Type in 2020
Figure 46. India Antiretroviral Therapy Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Antiretroviral Therapy
Figure 49. Manufacturing Process Analysis of Antiretroviral Therapy
Figure 50. Antiretroviral Therapy Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed